Clinical Trial search tool for Takeda sponsored clinical trials and provide easy searchability for information on a particular condition/disease; available clinical trials near a defined location; clinical trial entry criteria and design elements, as
Clinical Trial search tool for Takeda sponsored clinical trials and provide easy searchability for information on a particular condition/disease; available clinical trials near a defined location; clinical trial entry criteria and design elements, as
When was the clinical trial conducted? Aug 2020- Nov 2025 Key requirements All Age 18+ Years Healthy volunteers? No Inclusion Criteria: 1. Has a histologically or cytologically documented, advanced (metastatic and/or unresectable) cancer as listed below that is incurable: Note: Prior neoadjuvant ...
In total, these non-clinical studies suggest that TAK-285 may possess exploitable antineoplastic activity and consequently a phase I first-in-human study in patients with solid tumours was conducted in Japan. PATIENTS AND METHODS Trial design This was a phase I, multicentre, open-label study, ...
Clinical Trial 分子量 547.96 Formula C26H25ClF3N5O3 CAS 号 871026-44-7 运输条件 Room temperature in continental US; may vary elsewhere. 储存方式 溶解性数据 In Vitro: DMSO : ≥ 50 mg/mL(91.25 mM) *“≥” means soluble, but saturation unknown. ...
③The Lancet Infectious Diseases:Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial 巴西成年卫生保健工作者接种卡介苗预防结核分枝杆菌感染的效果:一项巢式临床试验 DOI: 10.1016/S1473-3099(23)00818-6 ...
Thus, we aimed to determine the activity of orteronel, a CYP17 inhibitor, in advanced disease.We designed a multicentric open-label phase II clinical trial. Eligible patients were adult woman with advanced or unresectable GCTs. Primary objective was clinical benefit rate, defined as the average...
It is a Multi-National Clinical Trial Joined by Five Countries/Territories in Asia--The First Time Takeda has Developed Medicines in Asia in Parallel with the Rest of the World The Trial Hopes to Show that TAK-875 Can Provide Excellent Blood Sugar Control but with a Very Low Risk of Hypogl...
Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competi... et al.Randomised clinical trial:safety,tolerability,pharmacokinetics and pharmacodynamics of repeated doses of TAK-438(vonoprazan),a novel ...
Professor Leung has published more than 280 papers in international peer reviewed journals. His current H-index is 38. He is also invited into the editorial board of international journals such as British Journal of Obstetricis and Gynaecology,American Journal of Perinatology,Pediatric Research(Fetus ...